JP Morgan Chase
CANO

JP Morgan Chase’s Cano Health, Inc. CANO Stock Holding History

JP Morgan Chase’s Portfolio CANO Stock Details CANO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-6,377
Closed -$5.68M – 7154
2021
Q4 		$5.68M Buy
+6,377
New +$6.7M ﹤0.01% 2952

Other funds holding CANO

SOW
State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
GFPC
Global Financial Private Client Sarasota, Florida $369M AUM 34.4% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
CP
Castleview Partners Dallas, Texas $228M AUM 19.85% 1-Year Est. Return

JP Morgan Chase's CANO Position: Q1 2024 in Review

JP Morgan Chase sold out of Cano Health, Inc. (CANO) in Q1 2024, closing a stake of 1,704 shares — an estimated $10K sold.

JP Morgan Chase first reported a position in CANO in Q4 2020 and held it in 10 quarters. The position peaked at $138M in Q3 2022. 6 funds tracked by Wall St. Rank hold CANO as of Q1 2024.

  • JP Morgan Chase reported no remaining Cano Health, Inc. position as of Q1 2024 after selling out during the quarter.
  • JP Morgan Chase sold 1,704 Cano Health, Inc. shares in Q1 2024, an estimated $10K.
  • JP Morgan Chase first reported a position in Cano Health, Inc. in Q4 2020 and held it in 10 quarters.
  • JP Morgan Chase's Cano Health, Inc. position peaked at $138M in Q3 2022.
  • 6 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q1 2024.

Based on JP Morgan Chase's 13F filing for Q1 2024, filed 10 May 2024.